Finn Egil Skjeldestad

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

Luisa L. Villa, Ronaldo Lúcio Rangel Costa, Carlos Alberto Petta et al. · The Lancet Oncology · 2005 · 1.6K citations

Vaccination, Vaccinology, Vaccine Development +9

Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9

Lars Nielsen, Charlotte Wessel Skovlund, Finn Egil Skjeldestad · BMJ · 2011 · 594 citations · Full text

Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium—a register-based case-control study

Anne Flem Jacobsen, Finn Egil Skjeldestad, Per Morten Sandset · American Journal of Obstetrics and Gynecology · 2007 · 468 citations

Thrombosis, Venous Thrombosis, Cardiovascular Disease +10

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

Luisa L. Villa, Kevin A. Ault, Anna R. Giuliano et al. · Vaccine · 2006 · 465 citations

Vaccination, Vaccine Development, Human Papillomavirus Vaccines +9

Ante- and postnatal risk factors of venous thrombosis: a hospital-based case–control study

Anne Flem Jacobsen, Finn Egil Skjeldestad, Per Morten Sandset · Journal of Thrombosis and Haemostasis · 2008 · 397 citations

Thrombosis, Venous Disease, Venous Thrombosis +14